Dennis L. Winger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), bought 6,500 shares at $38.54 ($251K) on 2010-02-16, disclosed to the SEC on 2010-02-18.
Open-market purchase of $251k VRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PCRX | BUY | 2014-12-08 | $250K | — | Filing → |
| ARAY | BUY | 2013-03-05 | $86K | — | Filing → |
| NKTR | BUY | 2012-09-18 | $46K | — | Filing → |